Ridge AugmentationNCT05407363
Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft
A study testing ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement in people with Ridge Augmentation and Implant, run by Kafrelsheikh University at 1 site in Egypt.
Trial summary
Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Ridge Augmentation, Implant, Autogenous Tooth Graft
- What is being tested?
- ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Apr 2022to 20 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Teeth with buccal bone destruction by periodontal disease and need extraction (horizontal or vertical bone defect);
- Absence of acute inflammation;
- Absence of uncontrolled systemic illness that would preclude implantation;
- Good dental and systemic healthy conditions;
- Patients were willing and able to return for multiple follow-up visits.
Who cannot join
- Patients with systemic illnesses,
- psychological abnormalities,
- para-functional habit,
- smokers or alcoholics,
- pregnant and lactating patients,
- patients undergoing or recently completed radiotherapy or chemotherapy,
- patients on drugs affecting the healing process,
- patients with endodontically treated teeth
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Faculty of Dentistry, Kafrelsheikh University
Kafr ash Shaykh, 33511
About this study
Official title: Ridge Augmentation With Simultaneous Implant Placement Using Xenogenic Blocks or Autogenous Bone Blocks With Autogenous Tooth Graft
Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. However, the amount of autogenous bone that may be harvested is limited, and the harvesting procedure is traumatic.
Bone substitutes, including allografts, xenografts, and alloplasts have been used successfully as alternatives to autogenous bone grafts in ridge augmentation procedures.
Read more
In 2008, autogenous tooth bone graft (ATG) was introduced and used for the first time as a bone grafting material for GBR. The tooth contents are extremely similar to that of the alveolar bone. The enamel inorganic, organic, and water contents are 95 percent, 0.6 percent, and 4 percent, respectively. However, in the dentin, the percentages are 70 to 75 percent, 20 percent, and 10 percent, respectively. They are 65 percent, 25 percent, and 10 percent, respectively, when compared to the alveolar bone content.
The aim of this study is to compare ridge augmentation using autogenous bone block (ABB) with immediate implant placement and filling the generated gap with autogenous bone graft (ABG) or ATG, or ridge augmentation using xenograft bone block (XBB) with immediate implant placement and filling the generated gap with ATG.
- Conditions
- Ridge Augmentation, Implant, Autogenous Tooth Graft
- Being tested
- ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement, ABB and ABG with simultaneous implant placement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ABB and ATG with simultaneous implant placementProcedure or surgery
Ridge augmentation using ABB and ATG as a graft material with simultaneous implant placement
XBB and ATG with simultaneous implant placementProcedure or surgery
Ridge augmentation using XBB and ATG as a graft material with simultaneous implant placement
ABB and ABG with simultaneous implant placementProcedure or surgery
Ridge augmentation using ABB and ABG as a graft material with simultaneous implant placement
| Study group | Role | What they receive |
|---|---|---|
| ABB and ATG with simultaneous implant placement | Experimental | Using ABB with ATG to fill the gap around simultaneously placed dental implants Receives: Procedure: ABB and ATG with simultaneous implant placement |
| XBB and ATG with simultaneous implant placement | Experimental | Using XBB with ATG to fill the gap around simultaneously placed dental implants Receives: Procedure: XBB and ATG with simultaneous implant placement |
| ABB and ABG with immediate implant | Active comparator | Using ABB with ABG to fill the gap around immediately placed dental implants Receives: Procedure: ABB and ABG with simultaneous implant placement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants
Changes on pocket depth and amount of bone using ABG or ATG with ABB or XBB around simultaneously placed dental implants
Measured: 9 months
radiographic outcome measuring the amount of bone around simultaneously placed dental implants
the radiographic outcome by measuring the amount of bone by using ATG or ABG on bone formation with ABB or XBB around simultaneously placed dental implants
Measured: 9 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jun 2022
- Study start1 Apr 2022
- Primary completion12 Aug 2023
- Study completion20 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ridge AugmentationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kafrelsheikh University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dalia Rasheed Issa, Kafrelsheikh University
- Investigators
- Dalia R Issa, PhD, Principal investigator, Kafrelsheikh University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05407363
- Sponsor's protocol ID
- KFSIRB200-72
- Status last verified
- Dec 2023
- First submitted
- 1 Apr 2022
- Last updated
- 22 Dec 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ridge Augmentation With Simultaneous Implant Placement Using Xenogenic Blocks or Autogenous Bone Blocks With Autogenous Tooth Graft
- ClinicalTrials.gov ID
- NCT05407363
- Acronym / sponsor ID
- KFSIRB200-72
- Conditions
- Ridge Augmentation, Implant, Autogenous Tooth Graft
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Kafrelsheikh UniversityUniversity, hospital or other
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- 12 Aug 2023 (actual)
- Study completion
- 20 Aug 2023 (actual)
- First posted
- 7 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. However, the amount of autogenous bone that may be harvested is limited, and the harvesting procedure is traumatic.
Bone substitutes, including allografts, xenografts, and alloplasts have been used successfully as alternatives to autogenous bone grafts in ridge augmentation procedures.
In 2008, autogenous tooth bone graft (ATG) was introduced and used for the first time as a bone grafting material for GBR. The tooth contents are extremely similar to that of the alveolar bone. The enamel inorganic, organic, and water contents are 95 percent, 0.6 percent, and 4 percent, respectively. However, in the dentin, the percentages are 70 to 75 percent, 20 percent, and 10 percent, respectively. They are 65 percent, 25 percent, and 10 percent, respectively, when compared to the alveolar bone content.
The aim of this study is to compare ridge augmentation using autogenous bone block (ABB) with immediate implant placement and filling the generated gap with autogenous bone graft (ABG) or ATG, or ridge augmentation using xenograft bone block (XBB) with immediate implant placement and filling the generated gap with ATG.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| ABB and ATG with simultaneous implant placement | Experimental | Procedure: ABB and ATG with simultaneous implant placementUsing ABB with ATG to fill the gap around simultaneously placed dental implants |
| XBB and ATG with simultaneous implant placement | Experimental | Procedure: XBB and ATG with simultaneous implant placementUsing XBB with ATG to fill the gap around simultaneously placed dental implants |
| ABB and ABG with immediate implant | Active comparator | Procedure: ABB and ABG with simultaneous implant placementUsing ABB with ABG to fill the gap around immediately placed dental implants |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Teeth with buccal bone destruction by periodontal disease and need extraction (horizontal or vertical bone defect);
- Absence of acute inflammation;
- Absence of uncontrolled systemic illness that would preclude implantation;
- Good dental and systemic healthy conditions;
- Patients were willing and able to return for multiple follow-up visits.
Key exclusion criteria (8 listed)
- Patients with systemic illnesses,
- psychological abnormalities,
- para-functional habit,
- smokers or alcoholics,
- pregnant and lactating patients,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ABB and ATG with simultaneous implant placementRidge augmentation using ABB and ATG as a graft material with simultaneous implant placement | Procedure or surgery | ABB and ATG with simultaneous implant placement |
| XBB and ATG with simultaneous implant placementRidge augmentation using XBB and ATG as a graft material with simultaneous implant placement | Procedure or surgery | XBB and ATG with simultaneous implant placement |
| ABB and ABG with simultaneous implant placementRidge augmentation using ABB and ABG as a graft material with simultaneous implant placement | Procedure or surgery | ABB and ABG with immediate implant |
Primary outcome
Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants
Time frame: 9 months
Changes on pocket depth and amount of bone using ABG or ATG with ABB or XBB around simultaneously placed dental implants
radiographic outcome measuring the amount of bone around simultaneously placed dental implants
Time frame: 9 months
the radiographic outcome by measuring the amount of bone by using ATG or ABG on bone formation with ABB or XBB around simultaneously placed dental implants
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2023.
Related trials for Ridge Augmentation
Not yet recruitingPhase 1/2
Alveolar Ridge Preservation (ARP) Study Using Alloplastic Biomaterial and a Resorbable Synthetic Membrane. A Digital Workflow (CBCT/Scanner) Evaluates Hard and Soft Tissue Volumetric Changes at 4 Months, Validating Support for the Gingival Phenotype and Buccal Bone Plate.
Alveolar Ridge Augmentation, Bone Substitutes
Active, not recruiting
Vallomix Socket Preservation Study
Alveolar Ridge Augmentation
Not yet recruiting
Shell Technique for Implant Site Development
Ridge Augmentation, Ridge Deficiency
Not yet recruiting
Effectiveness of Subepithelial Connective Tissue Graft as an Autogenous Barrier Membrane for Hard and Soft Tissue Augmentation in Horizontally Deficient Ridges During Delayed Implant Placement
Horizontally Deficient Alveolar Ridges, Hard and Soft Tissue Augmentation During Delayed Implant Placement
Not yet recruiting
Autogenous Sticky Bone Plus Platelet-rich Fibrin Membrane Versus Xenograft With Collagen Membrane for Posterior Atrophic Mandible
Ridge Augmentation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dalia R Issa, PhD principal investigator
Kafrelsheikh University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement in people with Ridge Augmentation and Implant, run by Kafrelsheikh University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants (time frame: 9 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2023; AzTrials last refreshed its copy on 29 Oct 2026.